Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Lunai Bioworks Inc.

NASDAQ: LNAI · Life Sciences · 4 alerts · CIK 1527728

Share price
$0.1648Close, Oct 29
Market cap
$830K
Shares outstanding
5.03MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Lunai Bioworks Inc. filings on SEC EDGAR ↗

4:56 PM ET 10-K
Financial Results

Lunai Bioworks FY 2026 Results: Net Loss of $3.56M, Loss Narrows

Lunai Bioworks Inc. (formerly Renovaro Biosciences) is navigating a complex regulatory landscape for its AI-driven diagnostic and therapeutic platforms, including compliance with the EU AI Act and shifting US federal oversight. The company is currently advancing pre-clinical candidates RENB-DC-11 for solid tumors and BioS_831 for epilepsy, while facing significant competition from larger pharmaceutical entities.

Key figure
Net loss $3.56M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.